Abstract
ObjectivesThe therapeutic effect of poly(ADP-ribose) polymerase inhibitors in patients with epithelial ovarian cancer (EOC) with somatic BRCA mutations is consistent with that observed in patients with germline BRCA mutations, indicating...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have